June 25, 2021
2 mins read

Single dose of Pfizer, AZ offers 60% protection

The team analysed 10,412 care home residents aged 65 years and older from 310 facilities, with a median age of 86 years. Of these 1,155 residents had evidence of previous SARS-CoV-2 infection…reports Asian Lite News.

A single dose of either the Pfizer or AstraZeneca Covid-19 vaccine offers around 60 per cent protection against infection from SARS-CoV-2, the virus causing Covid-19, in adults aged 65 years and above, according to a new study published in the The Lancet Infectious.

The study, led by researchers from the University College London, in the UK showed that the protective effect of a single dose of vaccination is evident from four weeks to at least seven weeks after vaccination, which provides some evidence to support extension of the interval between doses beyond three weeks, in line with UK policy.

vaccine

“However, even beyond four weeks, a single vaccine dose does not eliminate infection risk, highlighting the continued importance of non-pharmaceutical measures to control transmission within long-term care facilities,” said Madhumita Shrotri and Laura Shallcross, from the UCL Institute of Health Informatics.

The study will be critical to inform policy decisions regarding revaccination schedules in this vulnerable population and the disease control measures needed in the short, medium, and long term to protect long-term care facilities from future waves of SARS-CoV-2 infection, the team said.

The team analysed 10,412 care home residents aged 65 years and older from 310 facilities, with a median age of 86 years. Of these 1,155 residents had evidence of previous SARS-CoV-2 infection.

A total of 9,160 (88 per cent) residents received at least one vaccine dose during the study period, of whom 6,138 (67 per cent) received AstraZeneca (ChAdOx1) and 3,022 (33 per cent) received Pfizer (BNT162b2).

Between December 8, 2020 and March 15, 2021, there were 36,352 PCR tests carried out, with 1,335 PCR-positive infections detected (713 in unvaccinated residents and 612 in vaccinated residents).

The risk of infection was 56 per cent lower in vaccinated residents after 28 to 34 days, days, and 62 per cent lower at 35-48 days. Similar effect sizes at 35-48 days were seen for the AstraZeneca vaccine (68 per cent reduced risk of infection) and the Pfizer vaccine (65 per cent reduced risk).

The study will be presented at the 2021 European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) to be held from July 9-12.

ALSO READ-UK Begins Talks To Join Trans-Pacific Trade Bloc

READ MORE-MEA says overseas vaccine supply will depend on availability

Previous Story

J&K’s road ,rail networks get facelift

Next Story

‘India can be global leader in green buildings’

Latest from -Top News

Pakistan in the Dark: Power Crisis Boils Over

Regular power outages are a fact of life in Pakistan, but recent developments suggest that the situation is escalating to new extremes….writes Nasir Khattak In early January 2025, a nerve-breaking power outage

Modi, MBZ talk big ties

The call reaffirmed their keenness to “strengthen relations in line with their shared vision to leverage opportunities and deepen strategic cooperation.”…reports Asian Lite News In a significant diplomatic engagement, Prime Minister Narendra

It’s Official: Trump Slaps 25% Tariff on India

Trump issues executive order formalising India’s tariff at 25 pc…reports Asian Lite News New York, Aug 1 (IANS) As the deadline for tariffs neared, US President Donald Trump imposed the threatened tariff

Balochistan not for sale, Trump told

Mir Yar Baloch asserted that Trump’s recognition of the oil and mineral reserves in the region is “indeed accurate.”…reports Asian Lite News Just after US President Donald Trump announced to help Pakistan
Go toTop

Don't Miss

UK’s fossil fuel car ban delay to stall investment

Last week Volvo Cars said it would cease making diesel

Tenth round of FTA talks with UK next month in India

UK demands encompass free cross-border data flows and a ban